TY - JOUR
T1 - Comparison of the sympathetic stimulatory abilities of B-type procyanidins based on induction of uncoupling protein-1 in brown adipose tissue (BAT) and increased plasma catecholamine (CA) in mice
AU - Nakagawa, Yuta
AU - Ishimura, Kana
AU - Oya, Satomi
AU - Kamino, Masaki
AU - Fujii, Yasuyuki
AU - Nanba, Fumio
AU - Toda, Toshiya
AU - Ishii, Takeshi
AU - Adachi, Takahiro
AU - Suhara, Yoshitomo
AU - Osakabe, Naomi
N1 - Funding Information:
FN and TT, salaried employees for a commercial company (Fujico. Co. Ltd.), provided experimental materials as flavan 3-ol fraction derived from black soybean seed coats to our research group without any financial support. This work was only supported by the Grant of Cross-Ministerial Strategic Innovation Promotion Program (SIP), Urgent Project for Development and Diffusion of Innovative Technology towards Realization of the Aggressive Agriculture, Forestry and Fisheries and JSPS KAKENHI Grant Number 17H00818. The funders did not play any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. (http://www8.cao.go.jp/cstp/gaiyo/sip/tojbasite. html).
Publisher Copyright:
© 2018 Nakagawa et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PY - 2018/7
Y1 - 2018/7
N2 - Objectives We previously found that elevated energy expenditure following a single oral dose of flavan 3-ols (FL), a mixture of catechins and B type procyanidins, is caused by sympathetic nerve activation. In the present study, we compared the activity of the FL components (-)-epicate-chin (EC; monomer), procyanidin B2 (B2; dimer), procyanidin C1 (C1; trimer), cinnamtannin A2 (A2; tetramer), and more than pentamer fraction (P5). Methods Male ICR mice were treated with a single oral dose of FL, EC, B2, C1, A2, or P5. The animals were sacrificed and blood and brown adipose tissue (BAT) sampled. The plasma catecholamine (CA) levels and BAT uncoupling protein (UCP)-1 mRNA expression were determined. Results A single dose of 10 mg/kg FL significantly increased plasma CA and UCP-1 mRNA levels. B2, C1, and A2, but not EC and P5 (all at 1 mg/kg), significantly increased plasma adrenaline levels. Plasma noradrenaline was significantly elevated by B2 and A2, but not by EC, C1, or P5. UCP-1 mRNA levels were significantly increased by C1 and P5. In the dose response study of A2, 10−3 mg/kg A2 increased UCP-1 mRNA levels significantly, but not 10−2 and 10−1 mg/kg A2. In addition, combination treatment with 10−1 mg/kg A2 and yohimbine, an α2 adrenalin blocker, remarkably increased UCP-1 mRNA levels. Conclusion These results suggest that FL and its components, except EC, increase UCP-1 mRNA and plasma CA with varying efficacy.
AB - Objectives We previously found that elevated energy expenditure following a single oral dose of flavan 3-ols (FL), a mixture of catechins and B type procyanidins, is caused by sympathetic nerve activation. In the present study, we compared the activity of the FL components (-)-epicate-chin (EC; monomer), procyanidin B2 (B2; dimer), procyanidin C1 (C1; trimer), cinnamtannin A2 (A2; tetramer), and more than pentamer fraction (P5). Methods Male ICR mice were treated with a single oral dose of FL, EC, B2, C1, A2, or P5. The animals were sacrificed and blood and brown adipose tissue (BAT) sampled. The plasma catecholamine (CA) levels and BAT uncoupling protein (UCP)-1 mRNA expression were determined. Results A single dose of 10 mg/kg FL significantly increased plasma CA and UCP-1 mRNA levels. B2, C1, and A2, but not EC and P5 (all at 1 mg/kg), significantly increased plasma adrenaline levels. Plasma noradrenaline was significantly elevated by B2 and A2, but not by EC, C1, or P5. UCP-1 mRNA levels were significantly increased by C1 and P5. In the dose response study of A2, 10−3 mg/kg A2 increased UCP-1 mRNA levels significantly, but not 10−2 and 10−1 mg/kg A2. In addition, combination treatment with 10−1 mg/kg A2 and yohimbine, an α2 adrenalin blocker, remarkably increased UCP-1 mRNA levels. Conclusion These results suggest that FL and its components, except EC, increase UCP-1 mRNA and plasma CA with varying efficacy.
UR - http://www.scopus.com/inward/record.url?scp=85050848974&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85050848974&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0201203
DO - 10.1371/journal.pone.0201203
M3 - Article
C2 - 30059510
AN - SCOPUS:85050848974
SN - 1932-6203
VL - 13
JO - PLoS One
JF - PLoS One
IS - 7
M1 - e0201203
ER -